Doxazosin Tablet
Product Images NDC 71205-690

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 71205-690). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-690-30 (Doxazosin 4mg 100)

Doxazosin 4 mg oral tablets packaging label by Proficient Rx LP, containing 30 tablets. The label states each tablet contains Doxazosin Mesylate USP equivalent to 4 mg Doxazosin, describes tablet appearance, and provides storage instructions and manufacturer details as Intas Pharmaceuticals Limited, India.*

FDA Label Image

Table 1 (Doxazosin Fig1)

Table titled 'Summary of Effectiveness Data in Placebo Controlled Trials' showing symptom scores and maximum flow rate changes in three studies comparing placebo, Doxazosin 4 mg, and Doxazosin 8 mg. The table includes numerical data on mean baseline, mean change for symptom scores, and maximum flow rate with corresponding sample sizes. A bar graph visualizes the symptom score and maximum flow rate changes from Study 2 with significant statistical markers noted.*

FDA Label Image

Figure 1 – Study 1 (Doxazosin Fig2)

Two line graphs depicting the efficacy of Doxazosin compared to placebo over a 14-week treatment period. The left graph shows the mean change in total symptom score from baseline, with Doxazosin demonstrating greater improvement. The right graph shows the mean increase in maximum urinary flow rate (mL/sec) from baseline, again with Doxazosin showing a larger increase. Sample sizes are noted as N=50 for Doxazosin and N=47 for placebo.*

FDA Label Image

Chemical Structure (Doxazosin Str)

Chemical structure of Doxazosin, depicted with methanesulfonate (CH3SO3H) as the salt form. The structure shows the detailed molecular arrangement including multiple ring systems and substituents characteristic of Doxazosin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.